摘要
目的分析新活素治疗急性失代偿性心衰的临床疗效。方法选择2020年1月至2021年1月于我院接受治疗的40例急性失代偿性心衰患者作为本次研究主体,根据随机数表法将这40例患者分为两组,对照组(20例)予以常规治疗,观察组(20例)使用新活素治疗,对两种治疗方案的临床疗效进行评价。结果治疗完成后,观察组治疗效果优于对照组,有统计学差异(P<0.05);观察组临床症状积分均低于对照组,有统计学差异(P<0.05);观察组脑钠肽水平均低于对照组,有统计学差异(P<0.05);观察组心功能指标改善优于对照组,有统计学差异(P<0.05);两组方案治疗不良反应差异无统计学意义(P>0.05)。结论使用新活素治疗急性失代偿性心衰患者的临床疗效确切,能有效缓解患者的临床症状,降低心衰指标,改善心功能,且不会增加治疗风险,值得应用。
Objective To analyze the clinical efficacy of Neoactivin in the treatment of acute decompensated heart failure.Methods Forty patients with acute decompensated heart failure who were treated in our hospital from January 2020 to January 2021 were selected as the subjects of this study.According to the random number table method,the 40 patients were divided into two groups,the control group(20 cases)was given conventional treatment,and the observation group(20 cases)was given neomycin treatment,and the clinical efficacy of the two treatment schemes were evaluated.Results After treatment,the treatment effect of the observation group was better than that of the control group,with statistical difference(P<0.05).The clinical symptom scores of the observation group were lower than those of the control group,with statistical difference(P<0.05).Brain natriuretic peptide level in observation group were lower than the control group,with statistical difference(P<0.05).The improvement of cardiac function indexes of the observation group was better than that of the control group,with statistical difference(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion The clinical effect of Neoactivin in the treatment of patients with acute decompensated heart failure is exact,which can effectively alleviate the clinical symptoms of patients,reduce heart failure indicators,improve heart function,and will not increase the risk of treatment,so it is worthy of application.
作者
石俊松
SHI Jun-song(Jieshou Peoples Hospital,Jieshou,Anhui 236500)
出处
《智慧健康》
2021年第19期113-115,共3页
Smart Healthcare
关键词
新活素
急性失代偿性心衰
疗效
Neoactivin
Acute decompensated heart failure
Curative effect
